Loratadine is a second-generation antihistamine drug for the treatment of allergic diseases including allergic rhinitis and ...

Objective: To compare loratadine with fexofenadine and placebo in relieving symptoms of seasonal allergic rhinitis (SAR). Design: A randomised, double-blind, double-dummy, placebo-controlled ...

Morepen Laboratories receives approval for Loratadine API in China, paving the way for significant market expansion and growth opportunities.

Loratadine, a widely prescribed second-generation antihistamine, is commonly used to treat allergic conditions such as hay ...

Morepen Laboratories advanced 2.22% to Rs 48.91 after the company announced that it has received approval from the Center for Drug Evaluation (CDE) of the National Medical Products Administration ...

The company commands an over 80 per cent market share in the US generics market for Loratadine, according to its filing ...

Gurugram: Morepen Laboratories Limited has received approval from the Center for Drug Evaluation (CDE) of the National ...

Objective: Corticosteroids are effective in controlling the inflammatory component of allergic rhinitis; however, evidence for the clinical efficacy of systemic corticosteroids in this disease is ...

Morepen Laboratories approved for Loratadine export to China, aiming to strengthen global position in anti-allergy API market.

Find all the commercial and brand names of generic drug called Loratadine. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...